In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RefleXion Medical Inc.

www.reflexionmedical.com

Latest From RefleXion Medical Inc.

Medtech Business Models: All Razor And No Blades – Is “Big Iron” Back In Vogue?

The conventional wisdom in the medtech industry is to pursue the “razor-razor blade” business model, as each placement of capital equipment generates a lucrative annuity of recurring revenues from disposables. The corollary to this conventional wisdom is that so-called “big iron” is to be avoided as, in sharp contrast, it suffers from greater early cash requirements and longer sales cycles that create difficulties forecasting quarterly revenues, and provides no annuities. But that view is no longer the only one that counts, Health Advances CEO Mark Speers argues.

Market Intelligence Business Strategies

Execs On The Move, June 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Deals Market Intelligence

VC Deals Analysis: Active Funding Year Continues In April

The medtech deal volume was similar to activity last year at this time, but the total deal value in April was nearly triple that of April 2015, according to an internal analysis.

Medical Device Strategy
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • RefleXion Medical Inc.
  • Senior Management
  • Todd Powell, Pres. & CEO
    Martyn Webster, CFO
    Sam Mazin, PhD, CTO
    Akshay Nanduri, VP, Strategy & Bus. Dev.
    David Larkin, VP, R&D
    Thorsten Melcher, PhD, CBO
  • Contact Info
  • RefleXion Medical Inc.
    Phone: (650) 239-9070
    25841 Industrial Blvd.
    Ste. 275
    Hayward, CA 94545
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register